Abstract:This paper discusses the dilemmas inherent in pursuing a philosophy of (drug) harm minimization. The dilemmas arise (i) because all drug control policies produce harms as well as benefits; (ii) because many of these harms and benefits cannot be measured; and (iii) because even when they can be measured, judgements about what harms matter the most are irreducibly political. The paper concludes by proposing that the interests of drug policy might be better served if we abandoned the idea of an overarching goal i… Show more
“…Weatherburn's debate piece [1] considers how we should respond to dilemmas in harm minimization policy and practice-a question of central importance. Until recently, however, it has occupied less attention than matters of evidence and the quest for measurable outcomes in this field.…”
Section: Donmentioning
confidence: 99%
“…and 'What principle should we adopt to make such decisions?' [1]. Weatherburn argues that such dilemmas are encountered in harm minimization because of: (i) the co-occurrence of harms and benefits in most harm minimization interventions; (ii) difficulties in measuring and comparing harms and benefits; and (iii) the 'irreducibly political' nature of judgements about which harms matter most.…”
Section: Donmentioning
confidence: 99%
“…harm minimization as a drug policy goal) [1]. The author's argument that the measurement problems in harm minimization render it ineffective as a guiding principle for drug policy relies heavily upon his 'goal-oriented' version of harm minimization that is rooted in (or requiring) empirical outcomes.…”
“…Weatherburn's debate piece [1] considers how we should respond to dilemmas in harm minimization policy and practice-a question of central importance. Until recently, however, it has occupied less attention than matters of evidence and the quest for measurable outcomes in this field.…”
Section: Donmentioning
confidence: 99%
“…and 'What principle should we adopt to make such decisions?' [1]. Weatherburn argues that such dilemmas are encountered in harm minimization because of: (i) the co-occurrence of harms and benefits in most harm minimization interventions; (ii) difficulties in measuring and comparing harms and benefits; and (iii) the 'irreducibly political' nature of judgements about which harms matter most.…”
Section: Donmentioning
confidence: 99%
“…harm minimization as a drug policy goal) [1]. The author's argument that the measurement problems in harm minimization render it ineffective as a guiding principle for drug policy relies heavily upon his 'goal-oriented' version of harm minimization that is rooted in (or requiring) empirical outcomes.…”
“…In her response to Weatherburn (2009a), van Beek accepts that drug related harms may not be directly comparable, but writes that we still need an 'overarching principle' to inform us what the goals of drug policy should be (Van Beek, 2009: 342). As Weatherburn (2009b) points out, she does not tell us what this principle is.…”
Section: Comparing Harms For Harm Minimisationmentioning
confidence: 99%
“…It then applies this hierarchy to policy issues such as the right to use drugs and the rights of drug 'addicts'. Finally, it applies this approach to a specific drug policy scenario that Weatherburn (2009a) presents as an irresolvable dilemma.…”
Background: It has recently been argued that drug-related harms cannot be compared, so making it impossible to choose rationally between various drug policy options. Attempts to apply international human rights law to this area are valid, but have found it difficult to overcome the problems in applying codified human rights to issues of drug policy. Method: This article applies the rationalist ethical argument of Gewirth (1978) to this issue. It outlines his argument to the 'principle of generic consistency' and the hierarchy of basic, nonsubtractive and additive rights that it entails. It then applies these ideas to drug policy issues, such as whether there is a right to use drugs, whether the rights of drug 'addicts' can be limited, and how different harms can be compared in choosing between policies. Result: There is an additive right to use drugs, but only insofar as this right does not conflict with the basic and nonsubtractive rights of others. People whose freedom to choose whether to use drugs is compromised by compulsion have a right to receive treatment. They retain enforceable duties not to inflict harms on others. Policies which reduce harms to basic and nonsubtractive rights should be pursued, even if they lead to harms to additive rights. Conclusion: There exists a sound, rational, extra-legal basis for the discussion of drug policy and related harms which enables commensurable discussion of drug policy options.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.